Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome (Q38178543)

30 August 2017

Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome (English)

1 reference

30 August 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Massimo Bellini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Corrado Blandizzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Stefano Milani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

G Bassotti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

15 January 2014

1 reference

Techniques in Coloproctology

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

613-621

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10151-013-1106-8

1 June 2020

exact match

0 references

cites work

Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Fundamentals of neurogastroenterology: basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Identification of cells that express 5-hydroxytryptamine1A receptors in the nervous systems of the bowel and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Mast cell expression of the serotonin1A receptor in guinea pig and human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

A proposed new nomenclature for 5-HT receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Mechanisms of action of the 5-HT1B/1D receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The distribution of 5-HT1D and 5-HT1E binding sites in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Actions of the 5-hydroxytryptamine 1 receptor agonist sumatriptan on interdigestive gastrointestinal motility in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Molecular biology of 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-HT3 receptor as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Gut pacemaker cells: the interstitial cells of Cajal (ICC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Serotonin augments gut pacemaker activity via 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Differential modulation of the 5-HT(4) receptor agonists and antagonist on rat learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT(4) receptors, a place in the sun: act two.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-Hydroxytryptamine stimulates human isolated atrium but not ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Distribution of the 5-HT5A serotonin receptor mRNA in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

21 January 2018

12 December 2020

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

1 reference

5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Neurochemical bases of visceral nociception: mathematical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Afferent pain pathways: a neuroanatomical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Visceral hypersensitivity: facts, speculations, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Neuroendocrine markers and psychological features in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Epidemiological aspects of irritable bowel syndrome in Europe and North America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Sex differences of brain serotonin synthesis in patients with irritable bowel syndrome using alpha-[11C]methyl-L-tryptophan, positron emission tomography and statistical parametric mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The relationship between somatisation and outcome in patients with severe irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Basic pathophysiologic mechanisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Subtypes of constipation predominant irritable bowel syndrome based on rectal perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Bad news from the brain: descending 5-HT pathways that control spinal pain processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Irritable bowel syndrome: new agents targeting serotonin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Review article: tegaserod

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Localization of 5-ht5A receptor-like immunoreactivity in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats

21 January 2018

1 reference

12 December 2020

Autoregulation of serotonin neurons: role in antidepressant drug action

1 reference

12 December 2020

Central processing of rectal pain: a functional MR imaging study

1 reference

12 December 2020

Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype

1 reference

12 December 2020

Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries.

1 reference

12 December 2020

Characterization of the human 5-hydroxytryptamine1B receptor

1 reference

12 December 2020

CGRP as a transmitter in the sensory pathway mediating peristaltic reflex

1 reference

12 December 2020

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

1 reference

12 December 2020

The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity

1 reference

12 December 2020

Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist

1 reference

12 December 2020

Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat

1 reference

12 December 2020

Serotonin: a mediator of the brain-gut connection

1 reference

12 December 2020

Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation

1 reference

12 December 2020

Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype

1 reference

12 December 2020

Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans

1 reference

12 December 2020

5-HT receptors mediating contractions of the isolated human coronary artery

1 reference

12 December 2020

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

1 reference

12 December 2020

Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients

1 reference

12 December 2020

Serotonin and its implication for the management of irritable bowel syndrome.

1 reference

12 December 2020

Rectal hypersensitivity in the irritable bowel syndrome

1 reference

12 December 2020

Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle

1 reference

12 December 2020

Cloning and functional characterization of the rat stomach fundus serotonin receptor

1 reference

12 December 2020

In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors

1 reference

12 December 2020

Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers

1 reference

12 December 2020

The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family

1 reference

12 December 2020

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus

1 reference

12 December 2020

The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation

1 reference

12 December 2020

Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron)

1 reference

12 December 2020